Form 4: HCA Healthcare COO Exercises SARs, Sells Shares

HCA Healthcare's EVP and COO, Jon M. Foster, exercised stock appreciation rights and subsequently sold shares to cover tax liabilities.

Summary

• Jon M. Foster, EVP and COO of HCA Healthcare, Inc., reported transactions on February 5, 2026.
• Exercised 29,330 Stock Appreciation Rights (SARs) with an exercise price of $139.06 per share.
• Acquired 29,330 shares of Common Stock as a result of the SAR exercise.
• Disposed of 16,076 shares of Common Stock at a price of $513.76 per share, likely to cover tax obligations related to the SAR exercise.
• The SARs had vested in four equal annual installments starting January 30, 2020, and had an expiration date of January 30, 2029.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting an executive realizing value from long-term incentives due to stock price appreciation, which is generally a good sign for shareholders, despite the partial sale for tax purposes.

Positives

• The executive exercised a significant number of Stock Appreciation Rights, indicating a realization of value from previously granted equity incentives.
• The exercise price of the SARs ($139.06) is significantly lower than the sale price of the shares ($513.76), suggesting substantial appreciation in HCA's stock value since the SAR grant.

Negatives

• A portion of the acquired shares (16,076 shares) was sold, reducing the executive's direct beneficial ownership, although this is a common practice for tax withholding.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that executive equity transactions, such as SAR exercises and subsequent share sales for tax purposes, are routine events in publicly traded companies. These transactions reflect the realization of long-term incentive compensation and are generally not indicative of a change in company fundamentals or executive sentiment beyond the mechanics of compensation plans.

Stakeholder Impact

• Shareholders: The exercise of SARs and subsequent sale for tax purposes by a key executive demonstrates the executive's realization of value from their equity compensation, which can be seen as a positive signal regarding past stock performance.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event involving the exercise of stock appreciation rights and a subsequent sale of shares to cover tax obligations. It does not provide new fundamental information about HCA Healthcare's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The transaction reflects the executive realizing value from previously granted incentives, which is a neutral to slightly positive signal regarding past stock performance, but not a catalyst for a 'buy' or 'sell' decision based solely on this filing.

Keywords

HCA Healthcare, HCA, Jon M. Foster, Insider Trading, Form 4, Stock Appreciation Rights, SARs, Executive Compensation, Stock Sale, Equity Incentive